Action A078650 G9PHARMA CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues G9pharma co., LTD

Actions

A078650

KR7078650009

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2022
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2022
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2021
G9pharma co., LTD cancelled the transaction announced on November 26, 2021
G9pharma co., LTD announced that it has received KRW 9.9999984 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.
G9pharma co., LTD announced that it has received KRW 5.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm
G9pharma co., LTD announced that it expects to receive KRW 1.5 billion in funding from Cypress Partners Co., Ltd.
G9pharma co., LTD announced that it has received KRW 9.99999775 billion in funding from Meritz Securities Co., Ltd., Investment Arm
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd..
G9pharma co., LTD announced that it expects to receive KRW 17.99999925 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd. for KRW 15.5 billion.
G9pharma co., LTD announced that it expects to receive KRW 25.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm
1EVOLUTION Marketing Research Inc. cancelled the acquisition of 99.99% stake in KOLEN PHILIPPINES INC from Kolen Co., Ltd.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A078650
  4. Actualités G9pharma co., LTD
  5. Autres langues